{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:03:28Z","timestamp":1783119808009,"version":"3.54.6"},"reference-count":42,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T00:00:00Z","timestamp":1190937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate potential associations of the PlA1\/A2 polymorphism of the platelet glycoprotein IIIa (GPIIIa) gene with susceptibility to, and clinical expression of, giant cell arteritis (GCA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred forty patients with biopsy\u2010proven GCA who were residents of Reggio Emilia, Italy, and 241 population\u2010based healthy controls from the same geographic area were genotyped for the PlA1\/A2 polymorphism of the platelet GPIIIa gene by molecular methods. The patients were divided into subgroups according to the presence or absence of polymyalgia rheumatica and cranial ischemic complications. The distribution of the PlA1\/A2 genotype was investigated, and odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The distribution of the PlA1\/A2 genotype differed significantly between GCA patients with and those without visual loss caused by anterior ischemic optic neuritis (<jats:italic>P<\/jats:italic> = 0.016, corrected <jats:italic>P<\/jats:italic> [<jats:italic>P<\/jats:italic><jats:sub>corr<\/jats:sub>] = 0.048). The PlA2 allele was found significantly more frequently in GCA patients with anterior ischemic optic neuritis than in those without anterior ischemic optic neuritis (<jats:italic>P<\/jats:italic> = 0.023, <jats:italic>P<\/jats:italic><jats:sub>corr<\/jats:sub> = 0.046, OR 2.4 [95% CI 1.2\u20134.8]). Homozygosity for the PlA2 allele was significantly more frequent among GCA patients with anterior ischemic optic neuritis than among those without (<jats:italic>P<\/jats:italic> = 0.019, <jats:italic>P<\/jats:italic><jats:sub>corr<\/jats:sub> = 0.038, OR 7.1 [95% CI 1.64\u201330.6]). Cranial ischemic complications occurred in 8 of 19 patients (42.1%) receiving antiplatelet therapy, compared with 22 of 118 patients (18.6%) not receiving such therapy (<jats:italic>P<\/jats:italic> = 0.03, OR 3.2 [95% CI 1.1\u20138.8]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings show that A2\/A2 homozygosity is associated with an increased risk of visual loss due to anterior ischemic optic neuritis in GCA patients. Antiplatelet therapy, however, was not effective in reducing the risk of ischemic events in this population of GCA patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.22922","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T17:47:07Z","timestamp":1191001627000},"page":"3502-3508","source":"Crossref","is-referenced-by-count":20,"title":["PlA1\/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis"],"prefix":"10.1002","volume":"56","author":[{"given":"Carlo","family":"Salvarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Farnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Macchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Bajocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grazia Catanoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Restuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ghinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Boiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011913"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21075"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200009000-00001"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000119761.27564.c9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022694"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00001"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20171"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22141"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10071"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648803"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V71.4.831.831","article-title":"The platelet membrane glycoprotein IIb\/IIIa complex","volume":"71","author":"Phillips DR","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood.V94.6.2039","article-title":"The human platelet \u03b1IIb gene is not closely linked to its integrin partner \u03b23","volume":"94","author":"Thornton MA","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.4.1142"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01327.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00781-2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.8.1005"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000132194.24663.3d"},{"key":"e_1_2_6_21_2","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a 5\u2010year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani C","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_22_2","first-page":"520","article-title":"Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern Europe","volume":"31","author":"Gonzalez\u2010Gay MA","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02577.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22359"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000145369.25558.b5"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/18.4.836"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X"},{"key":"e_1_2_6_28_2","first-page":"74","article-title":"Steroid therapy improves endothelial function in patients with biopsy\u2010proven giant cell arteritis","volume":"33","author":"Gonzalez\u2010Juanatey C","year":"2006","journal-title":"J Rheumatol"},{"issue":"20","key":"e_1_2_6_29_2","first-page":"S32","article-title":"Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis","volume":"18","author":"Uddhammar AC","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_30_2","first-page":"1737","article-title":"A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis","volume":"32","author":"Rueda B","year":"2005","journal-title":"J Rheumatol"},{"issue":"36","key":"e_1_2_6_31_2","first-page":"S18","article-title":"Interferon\u2010\u03b3 gene microsatellite polymorphisms in patients with biopsy\u2010proven giant cell arteritis and isolated polymyalgia rheumatica","volume":"22","author":"Gonzalez\u2010Gay MA","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27196"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1809"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.3.329"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114082"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30590296385.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1615644","article-title":"Platelet glycoprotein receptor IIIa polymorphism PlA1\/PlA2 and coronary risk: a meta\u2010analysis","volume":"85","author":"Di Castelnuovo A","year":"2001","journal-title":"Thromb Haemost"},{"issue":"9","key":"e_1_2_6_38_2","first-page":"S172","article-title":"The platelet glycoprotein IIIA polymorphism PlA2 and risk of thrombotic events in patients with antiphospholipid antibodies","volume":"41","author":"Sobel RE","year":"1998","journal-title":"Arthritis Rheum"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.781"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.9.1013"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.034"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02267.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E227"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.22922","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.22922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:23:26Z","timestamp":1696965806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.22922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,28]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1002\/art.22922"],"URL":"https:\/\/doi.org\/10.1002\/art.22922","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,28]]}}}